Brenton Saunders compensation by year
Bausch & Lomb Summary Compensation Table · all 3 fiscal years held| Component | FY2023 | FY2024 | FY2025 |
|---|---|---|---|
| Salary | $1,396,923 | $1,600,000 | $1,600,000 |
| Bonus | $6,500,000 | $0 | $0 |
| Stock awards | $27,870,000 | $16,106,834 | $23,778,578 |
| Option awards | $7,305,493 | $2,799,997 | $2,799,998 |
| Non-equity incentive | $2,181,436 | $3,338,400 | $4,000,000 |
| Pension and deferred compensation | $0 | $0 | $0 |
| All other | $55,199 | $15,525 | $15,750 |
| Total | $45,309,051 | $23,860,756 | $32,194,326 |
Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: Bausch & Lomb Corp DEF 14A filed April 10, 2026, accession 0001140361-26-014234, and prior-year filings. Open the filing on EDGAR.
How this page was built: the Bausch & Lomb Corp filed document, accession 0001140361-26-014234. Every figure is read from that document and cited to the page and table it appears in. Filed April 10, 2026.
Equity holdings
unvested awards at FY2025 year-end| Type | Unvested units | Value at year-end | Exercise price |
|---|---|---|---|
| RSU | 900,000 | $15,372,000 | — |
| RSU | 378,378 | $6,462,696 | — |
| RSU | 375,839 | $6,419,330 | — |
| RSU | 302,013 | $5,158,382 | — |
| RSU | 281,879 | $4,814,493 | — |
| RSU | 187,500 | $3,202,500 | — |
| RSU | 168,168 | $2,872,309 | — |
| RSU | 125,280 | $2,139,782 | — |
| RSU | 63,063 | $1,077,116 | — |
| RSU | 22,000 | $375,760 | — |
| RSU | 21,500 | $367,220 | — |
| Option | 379,404 | — | $16.85 |
Per the Outstanding Equity Awards at Fiscal Year-End table in Bausch & Lomb Corp's FY2025 proxy; value at the fiscal year-end close, as the company printed it. The 12 largest of 14 award rows shown.
Bausch & Lomb’s named executive officers, FY2025
as the company reported each| Named executive officer | Role | FY2025 total |
|---|---|---|
| Brenton Saunders · this page | Chairman of the Board and Chief Executive Officer | $32,194,326 |
| A. Robert Bailey | Executive Vice President and Chief Legal Officer | $3,632,951 |
| Yehia Hashad | Executive Vice President of Research & Development and Chief Medical Officer | $2,789,501 |
| Andrew Stewart | President, Global Pharmaceuticals and International Consumer | $2,500,253 |
Board service
Bausch & Lomb board · FY2022–FY2025How this board is paid
Company policy: Bausch & Lomb pays directors a $80,000 cash retainer and $250,000 in equity. As stated in Bausch & Lomb's FY2025 proxy.
The full Bausch & Lomb compensation record
free company briefThis page is one person within Bausch & Lomb's record. The company brief lists every named executive, each linking to their own page.
Peer companies
named in the Bausch & Lomb proxy · each links to its own free briefCompensation, the day it’s disclosed
The CompBrief Daily Digest lists the newest executive and director compensation disclosures as companies file them. Or order Bausch & Lomb's full Executive Compensation Report with peer benchmarking.
How this record is built
Every figure on this page is one figure from a public SEC filing, printed as the filing states it and cited to the document. Compensation totals are Bausch & Lomb's own disclosed totals, not summed by Velarion. Insider transactions are read from Form 4 filings and cover every line filed since the most recent proxy. Nothing is estimated by Velarion; where the company does not disclose a value the cell reads "—", and a section appears only where the company discloses the data. Corrections: records@velarion.ai.
Order BLCO
Add the email the receipt and the PDF go to, then press the report you want. Each button opens its own card payment on Stripe.